Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Direct Medical Costs of 3 Reportable Travel-Related Infections in Ontario, Canada, 2012-2014.

Savage RD, Rosella LC, Crowcroft NS, Horn M, Khan K, Holder L, Varia M.

Emerg Infect Dis. 2019 Aug;25(8):1501-1510. doi: 10.3201/eid2508.190222.

2.

Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic Review.

Dawoud DM, Haines A, Wonderling D, Ashe J, Hill J, Varia M, Dyer P, Bion J.

Pharmacoeconomics. 2019 Oct;37(10):1241-1260. doi: 10.1007/s40273-019-00814-4. Review.

PMID:
31179514
3.

Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.

Spees LP, Brewster WR, Varia MA, Weinberger M, Baggett C, Zhou X, Petermann VM, Wheeler SB.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):882-889. doi: 10.1158/1055-9965.EPI-18-0945. Epub 2019 Feb 7.

PMID:
30733307
4.

Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.

Spees LP, Wheeler SB, Varia M, Weinberger M, Baggett CD, Zhou X, Petermann VM, Brewster WR.

Gynecol Oncol. 2019 Jan;152(1):112-118. doi: 10.1016/j.ygyno.2018.11.010. Epub 2018 Nov 12.

PMID:
30442384
5.

Accuracy of health administrative data to identify cases of reportable travel or migration-related infectious diseases in Ontario, Canada.

Savage RD, Rosella LC, Crowcroft NS, Horn M, Khan K, Varia M.

PLoS One. 2018 Nov 7;13(11):e0207030. doi: 10.1371/journal.pone.0207030. eCollection 2018.

6.

Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis.

Dawoud DM, Smyth M, Ashe J, Strong T, Wonderling D, Hill J, Varia M, Dyer P, Bion J.

Res Social Adm Pharm. 2018 Oct 19. pii: S1551-7411(18)30652-1. doi: 10.1016/j.sapharm.2018.10.006. [Epub ahead of print]

PMID:
30389320
7.

Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010-2014.

Majerovich JA, Fernandes L, Varia M.

Can Commun Dis Rep. 2017 May 4;43(5):114-118. eCollection 2017 May 4.

8.

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.

Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O'Brien T, Lopez JI, Watkins TBK, Nicol D, Stares M, Challacombe B, Hazell S, Chandra A, Mitchell TJ, Au L, Eichler-Jonsson C, Jabbar F, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Stewart A, Xing W, Smith JC, Escudero M, Huffman A, Matthews N, Elgar G, Phillimore B, Costa M, Begum S, Ward S, Salm M, Boeing S, Fisher R, Spain L, Navas C, Grönroos E, Hobor S, Sharma S, Aurangzeb I, Lall S, Polson A, Varia M, Horsfield C, Fotiadis N, Pickering L, Schwarz RF, Silva B, Herrero J, Luscombe NM, Jamal-Hanjani M, Rosenthal R, Birkbak NJ, Wilson GA, Pipek O, Ribli D, Krzystanek M, Csabai I, Szallasi Z, Gore M, McGranahan N, Van Loo P, Campbell P, Larkin J, Swanton C; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):595-610.e11. doi: 10.1016/j.cell.2018.03.043. Epub 2018 Apr 12.

9.

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.

Arce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, Solomon I, Lesko MH, Ruef N, Roddie C, Henry JY, Spain L, Ben Aissa A, Georgiou A, Wong YNS, Smith M, Strauss D, Hayes A, Nicol D, O'Brien T, Mårtensson L, Ljungars A, Teige I, Frendéus B; TRACERx Melanoma; TRACERx Renal; TRACERx Lung consortia, Pule M, Marafioti T, Gore M, Larkin J, Turajlic S, Swanton C, Peggs KS, Quezada SA.

Cancer Cell. 2018 Apr 9;33(4):649-663.e4. doi: 10.1016/j.ccell.2018.02.010. Epub 2018 Mar 22.

10.

How Can We Keep Immigrant Travelers Healthy? Health Challenges Experienced by Canadian South Asian Travelers Visiting Friends and Relatives.

Savage RD, Rosella LC, Crowcroft NS, Arneja J, de Villa E, Horn M, Khan K, Varia M.

Qual Health Res. 2018 Mar;28(4):610-623. doi: 10.1177/1049732317746381. Epub 2017 Dec 14.

PMID:
29239271
11.

Technology and tuberculosis control: the OUT-TB Web experience.

Guthrie JL, Alexander DC, Marchand-Austin A, Lam K, Whelan M, Lee B, Furness C, Rea E, Stuart R, Lechner J, Varia M, McLean J, Jamieson FB.

J Am Med Inform Assoc. 2017 Apr 1;24(e1):e136-e142. doi: 10.1093/jamia/ocw130.

PMID:
27589943
12.

Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e557-65. doi: 10.1016/j.prro.2015.06.011. Epub 2015 Jul 2.

13.

Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy.

Ozen A, Falchook AD, Varia MA, Gehrig P, Jones EL.

Gynecol Oncol. 2015 Aug;138(2):429-33. doi: 10.1016/j.ygyno.2015.05.025. Epub 2015 May 27.

PMID:
26024766
14.

ACR appropriateness Criteria® advanced stage endometrial cancer.

Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK; Expert Panel on Radiation Oncology-Gynecology:.

Am J Clin Oncol. 2014 Aug;37(4):391-6. doi: 10.1097/COC.0000000000000098.

PMID:
24977691
15.

Patterns of local failure for sinonasal malignancies.

Fried DV, Zanation AM, Huang B, Hayes N, Weissler M, Hackman T, Shores C, Rosenman J, Morris DE, Funkhouser W, Varia M, Chera BS.

Pract Radiat Oncol. 2013 Jul-Sep;3(3):e113-e120. doi: 10.1016/j.prro.2012.07.001. Epub 2012 Aug 9.

PMID:
24674372
16.

Acr appropriateness Criteria management of vaginal cancer.

Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK.

Oncology (Williston Park). 2013 Nov;27(11):1166-73. Review.

17.

ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva.

Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR.

Am J Clin Oncol. 2013 Aug;36(4):415-22. doi: 10.1097/COC.0b013e318295af1d. Review.

PMID:
23872794
18.

Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer.

Wennemers M, Stegeman H, Bussink J, Versleijen-Jonkers YM, van Laarhoven HW, Raleigh JA, Varia MA, Sweep FC, Span PN.

Int J Biol Markers. 2013 Jun 28;28(2):151-60. doi: 10.5301/jbm.5000008.

PMID:
23558942
19.

Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation.

Fried D, Zanation AM, Huang B, Hayes N, Morris DE, Rosenman J, Varia M, Funkhouser W, Weissler M, Chera BS.

Laryngoscope. 2012 Oct;122(10):2210-5. doi: 10.1002/lary.23463. Epub 2012 Aug 9.

PMID:
22886723
20.

ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer.

Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK.

Am J Clin Oncol. 2012 Aug;35(4):399-405. doi: 10.1097/COC.0b013e3182610537. Review.

PMID:
22810416

Supplemental Content

Loading ...
Support Center